USPH Valuation
US Physical Therapy Inc
$
79.870
- Overview
- Forecast
- Valuation
- Earnings
USPH Relative Valuation
USPH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, USPH is overvalued; if below, it's undervalued.
Historical Valuation
US Physical Therapy Inc (USPH) is now in the Undervalued zone, suggesting that its current forward PE ratio of 28.12 is considered Undervalued compared with the five-year average of 34.96. The fair price of US Physical Therapy Inc (USPH) is between 92.51 to 114.14 according to relative valuation methord. Compared to the current price of 79.87 USD , US Physical Therapy Inc is Undervalued By 13.66%.
Relative Value
Fair Zone
92.51-114.14
Current Price：79.87
13.66%
Undervalued
28.62
PE
1Y
3Y
5Y
Trailing
Forward
17.15
EV/EBITDA
US Physical Therapy Inc. (USPH) has a current EV/EBITDA of 17.15. The 5-year average EV/EBITDA is 20.88. The thresholds are as follows: Strongly Undervalued below 15.84, Undervalued between 15.84 and 18.36, Fairly Valued between 23.41 and 18.36, Overvalued between 23.41 and 25.93, and Strongly Overvalued above 25.93. The current Forward EV/EBITDA of 17.15 falls within the Undervalued range.
20.11
EV/EBIT
US Physical Therapy Inc. (USPH) has a current EV/EBIT of 20.11. The 5-year average EV/EBIT is 22.61. The thresholds are as follows: Strongly Undervalued below 17.57, Undervalued between 17.57 and 20.09, Fairly Valued between 25.13 and 20.09, Overvalued between 25.13 and 27.65, and Strongly Overvalued above 27.65. The current Forward EV/EBIT of 20.11 falls within the Historic Trend Line -Fairly Valued range.
1.49
PS
US Physical Therapy Inc. (USPH) has a current PS of 1.49. The 5-year average PS is 2.29. The thresholds are as follows: Strongly Undervalued below 1.29, Undervalued between 1.29 and 1.79, Fairly Valued between 2.78 and 1.79, Overvalued between 2.78 and 3.28, and Strongly Overvalued above 3.28. The current Forward PS of 1.49 falls within the Undervalued range.
15.08
P/OCF
US Physical Therapy Inc. (USPH) has a current P/OCF of 15.08. The 5-year average P/OCF is 17.54. The thresholds are as follows: Strongly Undervalued below 11.03, Undervalued between 11.03 and 14.29, Fairly Valued between 20.80 and 14.29, Overvalued between 20.80 and 24.05, and Strongly Overvalued above 24.05. The current Forward P/OCF of 15.08 falls within the Historic Trend Line -Fairly Valued range.
18.62
P/FCF
US Physical Therapy Inc. (USPH) has a current P/FCF of 18.62. The 5-year average P/FCF is 21.86. The thresholds are as follows: Strongly Undervalued below 11.24, Undervalued between 11.24 and 16.55, Fairly Valued between 27.17 and 16.55, Overvalued between 27.17 and 32.48, and Strongly Overvalued above 32.48. The current Forward P/FCF of 18.62 falls within the Historic Trend Line -Fairly Valued range.
US Physical Therapy Inc (USPH) has a current Price-to-Book (P/B) ratio of 2.38. Compared to its 3-year average P/B ratio of 3.09 , the current P/B ratio is approximately -22.85% higher. Relative to its 5-year average P/B ratio of 3.79, the current P/B ratio is about -37.13% higher. US Physical Therapy Inc (USPH) has a Forward Free Cash Flow (FCF) yield of approximately 5.10%. Compared to its 3-year average FCF yield of 4.67%, the current FCF yield is approximately 9.27% lower. Relative to its 5-year average FCF yield of 5.07% , the current FCF yield is about 0.66% lower.
2.43
P/B
Median3y
3.09
Median5y
3.79
5.10
FCF Yield
Median3y
4.67
Median5y
5.07
Competitors Valuation Multiple
The average P/S ratio for USPH's competitors is , providing a benchmark for relative valuation. US Physical Therapy Inc Corp (USPH) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 18.04%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of USPH decreased by 5.62% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 7.01 to 8.98.
The secondary factor is the Revenue Growth, contributed 18.04%to the performance.
Overall, the performance of USPH in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
AMC
AMC Entertainment Holdings Inc
3.000
USD
-0.33%
SCS
Steelcase Inc
16.900
USD
+0.12%
BHLB
Berkshire Hills Bancorp Inc
26.130
USD
-0.65%
SGML
Sigma Lithium Corp
6.270
USD
+3.47%
SILA
Sila Realty Trust Inc
25.620
USD
-0.81%
GEL
Genesis Energy LP
16.290
USD
-1.51%
BLBD
Blue Bird Corp
60.860
USD
+1.93%
PBI
Pitney Bowes Inc
11.790
USD
0.00%
RBCAA
Republic Bancorp Inc
74.230
USD
-0.75%
TPC
Tutor Perini Corp
66.810
USD
+2.03%
FAQ
Is US Physical Therapy Inc (USPH) currently overvalued or undervalued?
US Physical Therapy Inc (USPH) is now in the Undervalued zone, suggesting that its current forward PE ratio of 28.12 is considered Undervalued compared with the five-year average of 34.96. The fair price of US Physical Therapy Inc (USPH) is between 92.51 to 114.14 according to relative valuation methord. Compared to the current price of 79.87 USD , US Physical Therapy Inc is Undervalued By 13.66% .
What is US Physical Therapy Inc (USPH) fair value?
How does USPH's valuation metrics compare to the industry average?
What is the current P/B ratio for US Physical Therapy Inc (USPH) as of Sep 23 2025?
What is the current FCF Yield for US Physical Therapy Inc (USPH) as of Sep 23 2025?
What is the current Forward P/E ratio for US Physical Therapy Inc (USPH) as of Sep 23 2025?